...
首页> 外文期刊>Irish journal of medical science >Six-year follow-up after Helicobacter pylori eradication in peptic ulcer disease.
【24h】

Six-year follow-up after Helicobacter pylori eradication in peptic ulcer disease.

机译:根除幽门螺杆菌后发生消化性溃疡病的六年随访。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: The longterm outlook after Helicobacter pylori (H. pylori) eradication in peptic ulcer disease is unclear. AIM: This study documents H. pylori recurrence, dyspeptic symptoms and anti-secretory therapy in peptic ulcer patients six years or more after H. pylori eradication. METHODS: Peptic ulcer patients with H. pylori eradication between 1990 and 1992 were included. Infection recurrence was diagnosed by 13-carbon urea breath test (UBT). Dyspeptic symptoms and anti-secretory therapy use were assessed by questionnaire. RESULTS: Sixty-one patients completed the study protocol. Mean follow-up after eradication was 6.1 years (range 4.8-8.3). Four patients had a positive UBT. H. pylori recurrence rate was 6.6% or 0.02% per patient per year. Forty-two patients (69%) had dyspeptic symptoms. Heartburn and belching were more common than pain (p<0.001). All four patients with H. pylori recurrence had symptoms compared with 38 of 57 H. pylori-negative patients (p>0.05). Ten of 61 patients (16.4%) were taking anti-secretory therapy and their dyspepsia scores were higher. CONCLUSIONS: Despite a low H. pylori recurrence rate, longterm dyspeptic symptoms were common in peptic ulcer patients after H. pylori eradication. The symptoms are mainly reflux in type and require anti-secretory therapy in only a minority of patients.
机译:背景:幽门螺杆菌(H. pylori)根除在消化性溃疡疾病中的长期前景尚不清楚。目的:本研究记录了根除幽门螺杆菌后六年或更长时间的消化性溃疡患者的幽门螺杆菌复发,消化不良症状和抗分泌疗法。方法:纳入1990至1992年间根除幽门螺杆菌的消化性溃疡患者。通过13碳尿素呼气试验(UBT)诊断感染复发。消化不良症状和抗分泌疗法的使用通过问卷进行评估。结果:61名患者完成了研究方案。根除后的平均随访时间为6.1年(范围4.8-8.3)。 4例患者UBT阳性。每位患者每年的幽门螺杆菌复发率为6.6%或0.02%。四十二名患者(69%)有消化不良症状。胃灼热和气比疼痛更常见(p <0.001)。与57例幽门螺杆菌阴性患者中的38例相比,所有4例幽门螺杆菌复发患者均具有症状(p> 0.05)。 61例患者中有10例(16.4%)正在接受抗分泌疗法,其消化不良评分更高。结论:尽管幽门螺杆菌的复发率较低,但根除幽门螺杆菌后的消化性溃疡患者长期存在消化不良症状。症状主要为反流,仅少数患者需要抗分泌治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号